预装组合尼古丁替代疗法在哈萨克斯坦戒烟:一个随机对照试验研究协议
Chethan Purushothama1, Byron Lawrence Crape2, Valentina Stolyarov2
1School of sciences & Humanities, Nazarbayev University, Nur-Sultan city, Republic of Kazakhstan.
PloS one
|November 27, 2023
概括
结合尼古丁替代疗法 (NRT) 在改善哈萨克斯坦的戒烟率方面显示出前景. 这项研究调查了与单个NRT相比,其在长期戒烟和生活质量方面的有效性.
科学领域:
- 公共卫生 公共卫生
- 临床试验 临床试验
- 成 药物 药物 药物 药物
背景情况:
- 烟草使用在哈萨克斯坦每年造成22,500多人死亡,尽管有控制工作,但与吸烟有关的死亡率仍在上升.
- 组合尼古丁替代疗法 (NRT) 显示,长期戒烟率高于单个NRT配方.
- 由于高吸烟率,哈萨克斯坦面临着重大的公共卫生挑战.
研究的目的:
- 评估预装组合NRT在戒烟方面的有效性.
- 评估戒烟后与健康有关的生活质量变化.
- 探索参与者对结合NRT的治疗坚持的看法.
主要方法:
- 一个随机的,单盲优越性试验,涉及200名参与者 (每只手臂100名) 在哈萨克斯坦阿斯塔纳.
- 激励戒烟的18岁以上的参与者将被随机分配到接受预装组合NRT或单独的快速起作用NRT.
- 主要结局:六个月后持续戒烟. 二次结果:与健康相关的生活质量和治疗坚持.
主要成果:
- 预计这项研究将提供证据,支持组合NRT的疗效,而不是单独的快速起作用NRT.
- 预期的结果可能表明,NRT组合组的长期戒烟率有所改善.
- 成功戒烟者预计将在与健康有关的生活质量方面取得潜在的改善.
结论:
- 与单个NRT相比,组合NRT可能是一种更有效的戒烟策略.
- 调查结果可以为哈萨克斯坦和类似高流行地区的烟草戒烟战略提供信息.
- 这项研究有助于理解NRT在公共卫生干预中的作用.
更多相关视频
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
14.3K
09:25Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
11.5K
相关概念视频
Drug Dependence
1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
